Imran Niazi, MD
Clinical Cardiac Electrophysiology · Milwaukee, WINPI 1689670754
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $759,890 of the $1,047,263 with a category attached, or 72.6%. Merit Medical Systems Inc accounts for 97.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $507,032 and has fallen 99.7% since, to $1,754 in 2025. Among clinical cardiac electrophysiology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $8181.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$1M
- Medtronic$12K
- Abbott$6K
- Altathera Pharmaceuticals LLC$2K
- Biotronik Inc.$2K
- Boston Scientific$1K
- plus $1K from 7 others
Across 77 payments — averaging $2297.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$79K
- Impulse Dynamics (USA) Inc.$53K
- Abbott$45K
What the payments were for
- Royalty or licence$759,89073%
- Consulting fees$9,1821%
- Speaking & faculty fees$7,2001%
- Travel & lodging$2,5920%
- Food & beverage$6,2741%
- Ownership interest$262,12525%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 11 | $1,022,015 |
| Medtronic(2 entities) | 52 | $12,469 |
| Abbott | 16 | $6,147 |
| Altathera Pharmaceuticals LLC | 2 | $2,031 |
| Biotronik Inc. | 10 | $1,852 |
| Boston Scientific | 12 | $1,394 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $915 |
| Impulse Dynamics (USA) Inc. | 2 | $150 |
| ZOLL Respicardia, Inc. | 1 | $137 |
| Biosense Webster, Inc. | 1 | $109 |
| Novartis | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Bardy Diagnostics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Worley Adv Coronary Sinus Gde$521,620
- Worley Adv Coronary Sinus Guide$500,395
- Endurity Pacemaker$5,732
- Micra$3,348
- Sotalol Hydrochloride$2,031
- COBALT DR MRI SURESCAN$423
- LINQ II$273
- WATCHMAN Access System$267
- GENERAL - THERAPIES$266
- OPTIMIZER$260
- Carto 3$218
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$166
- ENSITE PRECISION$163
- AURORA EV-ICD MRI SURESCAN$151
- PulseSelect$147
- remede System$137
- Claria MRI$122
- GENERAL - STRUCTURAL HEART$115
- EVERA MRI XT DR SURESCAN$111
How this compares
$1,047,263 in reported general payments places this provider in the 95th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
See all clinical cardiac electrophysiology providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 553 | $650,572 |
| XareltoRivaroxaban | 116 | $142,728 |
| MultaqDronedarone Hcl | 44 | $60,595 |
| EntrestoSacubitril/Valsartan | 61 | $47,444 |
| Dofetilide | 156 | $22,424 |
| VerquvoVericiguat | 11 | $7,609 |
| SotalolSotalol Hcl | 189 | $5,322 |
| Metoprolol Succinate | 351 | $4,363 |
| Flecainide Acetate | 76 | $4,049 |
| Nadolol | 39 | $3,251 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $3,236 |
| Amiodarone Hcl | 180 | $2,486 |
| Mexiletine Hcl | 20 | $2,062 |
| Verapamil SrVerapamil Hcl | 18 | $1,530 |
| Potassium Chloride | 70 | $1,215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $19 | $47,44461 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
Other clinical cardiac electrophysiology in Milwaukee
- Jodi ZilinskiMilwaukee$173K
- Marcie BergerMilwaukee$67K
- Mohammad MortadaMilwaukee$65K
- Andy KieuMilwaukee$62K
- Hannah WeyMilwaukee$48K
- Varun GargMilwaukee$43K
- Jasbir SraMilwaukee$38K
- Ahmed ElawadMilwaukee$19K
- John BirchakMilwaukee$19K
- James OujiriMilwaukee$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.